Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.8 USD | +1.17% | -2.34% | -12.38% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 0% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 47.58 times its estimated earnings per share for the ongoing year.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-12.38% | 242M | - | ||
-8.54% | 45.55B | A- | ||
-5.56% | 20.74B | A- | ||
+1.58% | 15.39B | A- | ||
+18.53% | 11.95B | A | ||
-3.40% | 9.92B | B+ | ||
-12.54% | 8.65B | B- | ||
-4.25% | 8.18B | A- | ||
+4.05% | 7.83B | A- | ||
-18.12% | 5.74B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NREF Stock
- Ratings NexPoint Real Estate Finance, Inc.